Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel Pharmaceuticals
What you'll get out of this episode:
- Discussing LUMRYZ, a new narcolepsy drug.
- Insights into the challenges of narcolepsy treatment.
- Avadel's future plans in healthcare innovation.
To learn more about Greg and Avadel Pharmaceuticals:
Guest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/
Website: https://www.avadel.com/
Company LinkedIn: https://www.linkedin.com/company/avadelpharmaceuticals/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/